Intervention Protocol

You have free access to this content

Transcatheter versus optimal medical treatment and surgical aortic valve replacement for aortic valve stenosis

  1. Hans GH Thyregod1,*,
  2. Christian H Møller1,
  3. Lars Søndergaard2,
  4. Christian Gluud3,
  5. Daniel A Steinbrüchel1

Editorial Group: Cochrane Heart Group

Published Online: 30 APR 2013

DOI: 10.1002/14651858.CD010488


How to Cite

Thyregod HGH, Møller CH, Søndergaard L, Gluud C, Steinbrüchel DA. Transcatheter versus optimal medical treatment and surgical aortic valve replacement for aortic valve stenosis (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD010488. DOI: 10.1002/14651858.CD010488.

Author Information

  1. 1

    Rigshospitalet, Copenhagen University Hospital, Department of Cardiothoracic Surgery, RT 2152, Copenhagen, Copenhagen, Denmark

  2. 2

    Rigshospitalet, Copenhagen University Hospital, Department of Cardiology, Copenhagen, Copenhagen, Denmark

  3. 3

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, The Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Hans GH Thyregod, Department of Cardiothoracic Surgery, RT 2152, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Copenhagen, 2100, Denmark. hgthyregod@gmail.com. hans.gustav.thyregod@rh.regionh.dk.

Publication History

  1. Publication Status: New
  2. Published Online: 30 APR 2013

SEARCH

References

Additional references

Andersen 1992
  • Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. European Heart Journal 1992;13:704-8.
Bach 2009
  • Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circulation: Cardiovascular Quality and Outcomes 2009;2:533-9.
Bonow 2008
  • Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Circulation 2008;118:e523-e661.
Brown 2009
  • Brown JM, O'Brien SM, Wu C, Sikora JAH, Griffith BP, Gammie JS. Isolatedaortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. Journal of Thoracic and Cardiovascular Surgery 2009;137:82-90.
Buellesfeld 2011
  • Buellesfeld L, Gerckens U, Schuler G, Bonan R, Kovac J, Serruys PW, et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. Journal of the American College of Cardiology 2011;57:1650-7.
Carabello 2009
  • Carabello BA, Paulus WJ. Aortic stenosis. Circulation 2009;14:956-66.
Chan 2010
  • Chan KL, Teo K, Dumesnil JG, Ni A, Tam J, ASTRONOMER Investigators. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010;121:306-14.
Clark 2012
  • Clark MA, Arnold SV, Duhay FG, Thompson AK, Keyes MJ, Svensson LG, et al. Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis. Cardiovascular Quality and Outcomes 2012;5:697-704.
Cribier 2002
  • Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8.
Cribier 2012
Dewey 2010
  • Dewey TM, Brown DL, Herbert MA, Culica D, Smith CR, Leon MB, et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Annals of Thoracic Surgery 2010;89:758-67.
Egger 1997
  • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
ElBardissi 2011
  • ElBardissi AW, Shekar P, Couper GS, Cohn LH. Minimally invasive aortic valve replacement in octogenarian, high-risk, transcatheter aortic valve implantation candidates. Journal of Thoracic and Cardiovascular Surgery 2011;141:328-35.
Florath 2003
  • Florath I, Rosendahl UP, Mortasawi A, Bauer SF, Dalladaku F, Ennker IC, et al. Current determinants of operative mortality in 1400 patients requiring aortic valve replacement. Annals of Thoracic Surgery 2003;76:75-83.
Florath 2010
  • Florath I, Albert A, Boening A, Ennker IC, Ennker J. Aortic valve replacement in octogenarians: identification of high-risk patients. European Journal of Cardiothoracic Surgery 2010;37:1304-10.
Freeman 2005
Gilard 2012
  • Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. New England Journal of Medicine 2012;366:1705-15.
Gluud 2006
Higgins 2002
Higgins 2003
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Horstkotte 1988
  • Horstkotte D, Loogen F. The natural history of aortic valve stenosis. European Heart Journal 1988;9(Supplement E):57-64.
ICH 1996
  • The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guideline for Good Clinical Practice E6 (R1). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf (accessed 13-02-2013) .
Iivanainen 1997
  • Iivanainen AM, Lindroos M, Tilvis R, Heikkila J, Kupari M. Natural history of aortic valve stenosis of varying severity in the elderly. American Journal of Cardiology 1996;78:97–101.
Iung 2003
  • Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. European Heart Journal 2003;24:1231-43.
Iung 2005
  • Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?. European Heart Journal 2005;26:2714-20.
Jilaihawi 2012
Kahlert 2010
  • Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010;121:870-8.
Kappetein 2013
  • Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. Journal of Thoracic and Cardiovascular Surgery 2013;145:6-23.
Khan 1998
Khawaja 2011
  • Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation 2011;123:951-60.
Kjaergard 2001
  • Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135:982-9.
Krane 2012
  • Krane M, Deutsch MA, Piazza N, Muhtarova T, Elhmidi Y, Mazzitelli D, et al. One-year results of health-related quality of life among patients undergoing transcatheter aortic valve implantation. American Journal of Cardiology 2012;109:1774-81.
Krayenbuehl 1988
  • Krayenbuehl HP, Hess OM, Ritter M, Monrad ES, Hoppeler H. Left ventricular systolic function in aortic stenosis. European Heart Journal 1988;9(Supplement E):19-23.
Leon 2011
  • Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. European Heart Journal 2011;32:205-17.
Leontyev 2009
  • Leontyev S, Walther T, Borger MA, Lehmann S, Funkat AK, Rastan A, et al. Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Annals of Thoracic Surgery 2009;87:1440-5.
Litzler 2012
  • Litzler PY, Borz B, Smail H, Baste JM, Nafeh-Bizet C, Gay A, et al. Transapical aortic valve implantation in Rouen: four years experience with the Edwards transcatheter prosthesis. Archives of Cardiovascular Diseases 2012;105:141-5.
Lund 1990
  • Lund O. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative intervention. Circulation 1990;82:124-39.
Lundh 2012
Macaskill 2001
Marcus 1982
  • Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL. Decreased coronary reserve: a mechanism for angina pectoris inpatients with aortic stenosis and normal coronary arteries. New England Journal of Medicine 1982;307:1362-6.
Moat 2011
  • Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. Journal of the American College of Cardiology 2011;58:2130-8.
Moher 1998
  • Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352:609-13.
Moher 2009
Murphy 1981
  • Murphy ES, Lawson RM, Starr A, Rahimtoola SH. Severe aortic stenosis in patients 60 years of age or older: left ventricular function and 10-year survival after valve replacement. Circulation 1981;64:184-8.
Mølstad 2012
  • Mølstad P, Veel T, Rynning S. Long-term survival after aortic valve replacement in octogenarians and high-risk subgroups. European Journal of Cardiothoracic Surgery 2012;42:934-40.
Nashef 1999
Nashef 2012
Nkomo 2006
Nuis 2011a
  • Nuis RJ, Piazza N, Van Mieghem NM, Otten AM, Tzikas A, Schultz CJ, et al. In-hospital complications after transcatheter aortic valve implantation revisited according to the valve academic research consortium definitions. Catheterization and Cardiovascular Interventions 2011;78:457-67.
Nuis 2011b
  • Nuis RJ, van Mieghem NM, van der Boon RM, van Geuns RJ, Schultz CJ, Oei FB, et al. Effect of experience on results of transcatheter aortic valve implantation using a Medtronic CoreValve System. American Journal of Cardiology 2011;107:1824-9.
O'Brien 2009
  • O'Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2 - isolated valve surgery. Annals of Thoracic Surgery 2009;88(1 Suppl):S23-42.
Otto 1997
  • Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, et al. Prospective study of asymptomatic valvular aortic stenosis clinical, echocardiographic and exercise predictors of outcome. Circulation 1997;95:2262-70.
Otto 1999
  • Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. New England Journal of Medicine 1999;341:142-7.
Pellikka 2005
  • Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290-5.
Pereira 2002
  • Pereira JJ, Lauer MS, Bashir M, Afridi I, Blackstone EH, Stewart WJ, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. Journal of the American College of Cardiology 2002;39:1356-63.
Piazza 2008
  • Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-9.
Review Manager 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rodés-Cabau 2011
  • Rodés-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. Journal of the American College of Cardiology 2011;57:18-28.
Rodés-Cabau 2012
  • Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. Journal of the American College of Cardiology 2012;60:1864-75.
Rosenhek 2000
Rosenhek 2010
Ross 1968
  • Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968;38(1 Suppl):61-7.
Rossebø 2008
  • Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. New England Journal of Medicine 2008;359:1343-56.
Royle 2003
  • Royle P, Waugh N. Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system. Health Technology Assessment 2003;7:iii, ix-x, 1-51.
Savović 2012
  • Savović J, Jones H, Altman D, Harris R, Jűni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technology Assessment 2012;16:1-82.
Schulz 1995
  • Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
Schwarz 1982
  • Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation 1982;66:1105-10.
Spann 1980
  • Spann JF, Bove AA, Natarajan G, Kreulen T. Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis. Circulation 1980;62:576-82.
Stewart 1997
  • Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. Journal of the American College of Cardiology 1997;29:630-4.
Stortecky 2012
  • Stortecky S, Wenaweser P, Diehm N, Pilgrim T, Huber C, Rosskopf AB, et al. Percutaneous management of vascular complications in patients undergoing transcatheter aortic valve implantation. Journal of the American College of Cardiology 2012;5:515-24.
Sweeting 2004
Thanassoulis 2013
  • Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, et al. CHARGE Extracoronary Calcium Working Group. Genetic associations with valvular calcification and aortic stenosis. New England Journal of Medicine 2013;368:503-12.
Thompson 2002
Thorlund 2011
  • Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). 2011. Copenhagen Trial Unit, Centre for Clinical Intervention Research. http://www.ctu.dk/tsa/files/tsa_manual.pdf (accessed 13-02-2013) .
Thourani 2011
  • Thourani VH, Ailawadi G, Szeto WY, Dewey TM, Guyton RA, Mack MJ, et al. Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Annals of Thoracic Surgery 2011;91:49-55.
Tissot 2011
  • Tissot CM, Attias D, Himbert D, Ducrocq G, Iung B, Dilly MP, et al. Reappraisal of percutaneous aortic balloon valvuloplasty as a preliminary treatment strategy in the transcatheter aortic valve implantation era. Eurointervention 2011;7:49-56.
Toggweiler 2012
  • Toggweiler S, Humphries KH, Lee M, Binder RK, Moss RR, Freeman M, et al. 5-year outcome after transcatheter aortic valve implantation. Journal of the American College of Cardiology 2012;61:413-9.
Trial Sequential Analysis 2011
  • Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. TSA software. 0.9 Beta. Copenhagen: Copenhagen Trial Unit, Centre for Clinical Intervention Research, 2011.
Turina 1987
Ussia 2012
  • Ussia GP, Barbanti M, Petronio AS, Tarantini G, Ettori F, Colombo A, et al. CoreValve Italian Registry Investigators. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. European Heart Journal 2012;33:969-76.
Vahanian 2008
  • Vahanian A, Alfieri OR, Al-Attar N, Antunes MJ, Bax J, Cormier B, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal 2008;34:1-8.
Vahanien 2012
  • Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). European Heart Journal 2012;33:2451-96.
Walther 2011
  • Walther T, Mollmann H, van Linden A, Kempfert J. Transcatheter aortic valve implantation transapical: step by step. Seminars in Thoracic and Cardiovascular Surgery 2011;23:55-61.
Webb 2011
Wendt 2009
  • Wendt D, Osswald BR, Kayser K, Thielmann M, Tossios P, Massoudy P, et al. Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. Annals of Thoracic Surgery 2009;88:468-74.
Wetterslev 2008
  • Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61:64-75.
Wetterslev 2009
  • Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Medical Research Methodology 2009;9:86.
Wood 2008
  • Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-5.
Ye 2010
  • Ye J, Cheung A, Lichtenstein SV, Nietlispach F, Albugami S, Masson JB, et al. Transapical transcatheter aortic valve implantation: follow-up to 3 years. Journal of Thoracic and Cardiovacular Surgery 2010;139:1107-13.
Zahn 2011
  • Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, et al. German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. European Heart Journal 2011;32:198-204.